Literature DB >> 16986018

Clinical impact of overactive bladder.

Victor W Nitti.   

Abstract

Overactive bladder (OAB) is a medical condition with the symptoms of urinary frequency and urgency, with or without urge incontinence. Traditionally, epidemiologic studies have focused on the symptom of incontinence, and therefore the prevalence and clinical impact have been grossly underestimated. Recently, several population-based studies have been conducted that have provided insight into the true magnitude of OAB. This article will review the latest data on the prevalence of OAB and discuss the impact of the condition on quality of life. Furthermore, it will examine some of the comorbidities associated with OAB and look at the potential economic impact of OAB.

Entities:  

Year:  2002        PMID: 16986018      PMCID: PMC1476019     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  16 in total

Review 1.  Overactive Bladder and Its Treatments Consensus Conference. London, United Kingdom, July 4, 1999.

Authors: 
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

2.  A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment.

Authors:  E Samuelsson; A Victor; G Tibblin
Journal:  Acta Obstet Gynecol Scand       Date:  1997-01       Impact factor: 3.636

3.  Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.

Authors:  A L Komaroff; L R Fagioli; T H Doolittle; B Gandek; M A Gleit; R T Guerriero; R J Kornish; N C Ware; J E Ware; D W Bates
Journal:  Am J Med       Date:  1996-09       Impact factor: 4.965

4.  Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey.

Authors:  J N Liberman; T L Hunt; W F Stewart; A Wein; Z Zhou; A R Herzog; R B Lipton; A C Diokno
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

5.  Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group.

Authors:  J S Brown; E Vittinghoff; J F Wyman; K L Stone; M C Nevitt; K E Ensrud; D Grady
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

Review 6.  Comorbidities associated with overactive bladder.

Authors:  J S Brown; W F McGhan; S Chokroverty
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

7.  The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population.

Authors:  Z Simeonova; I Milsom; A M Kullendorff; U Molander; C Bengtsson
Journal:  Acta Obstet Gynecol Scand       Date:  1999-07       Impact factor: 3.636

8.  Urinary incontinence and depression.

Authors:  B H Zorn; H Montgomery; K Pieper; M Gray; W D Steers
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

9.  Urinary incontinence in the community--analysis of a MORI poll.

Authors:  J C Brocklehurst
Journal:  BMJ       Date:  1993-03-27

10.  Urge incontinence: the patient's perspective.

Authors:  J S Brown; L L Subak; J Gras; B A Brown; M Kuppermann; S F Posner
Journal:  J Womens Health       Date:  1998-12       Impact factor: 2.681

View more
  7 in total

Review 1.  Solifenacin in overactive bladder syndrome.

Authors:  Dene Simpson; Antona J Wagstaff
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer.

Authors:  Daniel B Ng; Melissa McCart; Christopher Klein; Chelsey Campbell; Robert Schoenhaus; Todd Berner
Journal:  Am Health Drug Benefits       Date:  2016-09

3.  Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.

Authors:  Sender Herschorn; Jameel Nazir; Barbara Ramos; Zalmai Hakimi
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

4.  Social media analytics of overactive bladder posts: what do patients know and want to know?

Authors:  Gabriela Gonzalez; Kristina Vaculik; Carine Khalil; Yuliya Zektser; Corey W Arnold; Christopher V Almario; Brennan M R Spiegel; Jennifer T Anger
Journal:  Int Urogynecol J       Date:  2021-03-12       Impact factor: 1.932

5.  Treatment of overactive bladder syndrome with urethral calibration in women.

Authors:  Chao H Chen; Renee L Sato; Grace Hk Matsuura; David C Wei; John J Chen
Journal:  Hawaii J Med Public Health       Date:  2013-10

Review 6.  Botulinum toxin A for the Treatment of Overactive Bladder.

Authors:  Po-Fan Hsieh; Hung-Chieh Chiu; Kuan-Chieh Chen; Chao-Hsiang Chang; Eric Chieh-Lung Chou
Journal:  Toxins (Basel)       Date:  2016-02-29       Impact factor: 4.546

7.  Changes in urine headspace composition as an effect of strenuous walking.

Authors:  Devasena Samudrala; Brigitte Geurts; Phil A Brown; Ewa Szymańska; Julien Mandon; Jeroen Jansen; Lutgarde Buydens; Frans J M Harren; Simona M Cristescu
Journal:  Metabolomics       Date:  2015-05-31       Impact factor: 4.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.